CDT
Biotechnology · Healthcare
Chairman, Board Member
2023-01-01–present
Chairman
CDT Equity Inc. (CDT)Board Member
CDT Equity Inc. (CDT)Equibles does not estimate personal net worth.
Get an email with a short summary when CDT Equity Inc. publishes a filing, an earnings call transcript or a press release.
Get CDT alertsFreda Lewis-Hall is recorded as Chairman and Board Member at CDT Equity Inc. (CDT) since September 22, 2023. Freda Lewis-Hall was last confirmed as Board Member at Pyxis Oncology, Inc. (PYXS) in a filing dated April 28, 2023. CDT Equity Inc. reported in an 8-K filed April 27, 2026 that Freda Lewis-Hall resigned as chairperson on the Board, effective April 27, 2026. CDT Equity Inc. reported in an 8-K filed September 29, 2023 that Freda Lewis-Hall was appointed Chair of the Board, effective September 22, 2023. CDT Equity Inc. reported in an 8-K filed September 29, 2023 that Freda Lewis-Hall was appointed directors of the Company, effective September 22, 2023. CDT Equity Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CDT Equity Inc. includes Andrew Regan (CEO and Board Member), David Tapolczay (CEO and Board Member), James Bligh (CEO, CFO and Board Member) and 6 others.
“On April 27, 2026, Freda Lewis-Hall notified the Board of the Company of her decision to resign from the Board for family health reasons, vacating her role as chairperson on the Board, as chairperson of the Nominating and Corporate Governance Committee, and as a member of the Audit Committee and Compensation Committee, effective immediately.”
“Ms. Lewis-Hall was appointed as Chair of the Board.”
2023-09-22–present
2023-09-22–present
2023-09-22–2026-04-27
2023-01-01–2026-04-27
2021-01-01–2023-04-28
Last confirmed by a filing; no departure on record
CDT
Biotechnology · Healthcare
Chairman, Board Member
2023-01-01–present
PYXS
Biotechnology · Healthcare
Board Member
Since 2021-01-01, last confirmed 2023-04-28